Patterns of care in adjuvant systemic therapy of patients with stage III melanoma: A U.S. population-based study.
Against this backdrop, a team led by Professor Zhang Han and Associate Professor Chen Zhi from Shenzhen University in China , has demonstrated an innovative approach that combines DNA origami, CRISPR ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...
(San Diego, Calif.--September 7, 2024, 8:30 a.m. PCT) — Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic testing that offers an ...
SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...
The MarketWatch News Department was not involved in the creation of this content. Research presented today suggests an artificial intelligence tool called DeepGEM may provide an advancement in genomic ...
Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...